CHELSEA STRANG: Open Payments
NPI 1710498290 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 54 payments from 27 companies in 2025. Trend: 2023 $874 · 2024 $1,267 · 2025 $1,176
Food & beverage: $1,108Education: $68
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $169 |
| Janssen Biotech, Inc. | 4 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $104 |
| Genentech USA, Inc. | 4 | $79 |
| Incyte Corporation | 3 | $66 |
| BeOne Medicines USA, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| JAZZ PHARMACEUTICALS INC. | 2 | $46 |
Products named: KISQALI, IMFINZI, BRUKINSA, KEYTRUDA QLEX, ERLEADA, ZEPZELCA, Padcev, JAKAFI.
Industry payments across MI — which companies pay providers there.
